• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.调节性去甲肾上腺素转运体与神经激肽-1 受体的相互作用确立了转运体的亚细胞定位。
J Biol Chem. 2013 Oct 4;288(40):28599-610. doi: 10.1074/jbc.M113.472878. Epub 2013 Aug 26.
2
Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization.去甲肾上腺素转运体在苏氨酸258和丝氨酸259处的磷酸化与蛋白激酶C介导的转运体内化有关。
J Biol Chem. 2006 Aug 18;281(33):23326-40. doi: 10.1074/jbc.M601156200. Epub 2006 Jun 1.
3
Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization.佛波酯刺激下天然去甲肾上腺素转运体的调节性内化与磷酸化。定位于脂筏及脂筏介导的内化的证据。
J Biol Chem. 2004 Apr 30;279(18):19315-26. doi: 10.1074/jbc.M311172200. Epub 2004 Feb 19.
4
Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis.苏氨酸 258 和丝氨酸 259 基序在安非他命诱导的去甲肾上腺素转运体胞吞作用中的参与。
J Neurochem. 2010 Oct;115(1):23-35. doi: 10.1111/j.1471-4159.2010.06898.x. Epub 2010 Jul 30.
5
The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity.NK1受体定位于质膜微结构域,其激活依赖于脂筏的完整性。
J Biol Chem. 2005 Feb 25;280(8):7135-46. doi: 10.1074/jbc.M405806200. Epub 2004 Dec 8.
6
Subcellular localization of the antidepressant-sensitive norepinephrine transporter.抗抑郁药敏感性去甲肾上腺素转运体的亚细胞定位
BMC Neurosci. 2009 Jun 23;10:65. doi: 10.1186/1471-2202-10-65.
7
Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase.可卡因上调去甲肾上腺素转运蛋白需要 p38 丝裂原活化蛋白激酶对苏氨酸 30 的磷酸化。
J Biol Chem. 2011 Jun 10;286(23):20239-50. doi: 10.1074/jbc.M111.226811. Epub 2011 Apr 15.
8
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.内体中的神经激肽1受体信号传导介导持续的伤害感受,并且是实现长期疼痛缓解的可行治疗靶点。
Sci Transl Med. 2017 May 31;9(392). doi: 10.1126/scitranslmed.aal3447.
9
Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NKR) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva).选择性神经激肽 1 型受体(NKR)激动剂 GR73632 引起最小鼩鼱(Cryptotis parva)呕吐的细胞内催吐信号级联。
Neurochem Int. 2019 Jan;122:106-119. doi: 10.1016/j.neuint.2018.11.012. Epub 2018 Nov 16.
10
Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.神经激肽-1 拮抗剂区分了去甲肾上腺素转运体和多巴胺转运体在介导安非他命行为中的作用。
Pharmacology. 2021;106(11-12):597-605. doi: 10.1159/000518033. Epub 2021 Sep 2.

引用本文的文献

1
Role of Phosphorylation of Serotonin and Norepinephrine Transporters in Animal Behavior: Relevance to Neuropsychiatric Disorders.血清素和去甲肾上腺素转运体磷酸化在动物行为中的作用:与神经精神疾病的关联
Int J Mol Sci. 2025 Aug 9;26(16):7713. doi: 10.3390/ijms26167713.
2
Palmitoylation regulates norepinephrine transporter uptake, surface localization, and total expression with pathogenic implications in postural orthostatic tachycardia syndrome.棕榈酰化调节去甲肾上腺素转运体的摄取、表面定位和总表达,对体位性直立性心动过速综合征具有致病影响。
J Neurochem. 2025 Feb;169(2):e16241. doi: 10.1111/jnc.16241. Epub 2024 Oct 12.
3
Membrane Heteroreceptor Complexes as Second-Order Protein Modulators: A Novel Integrative Mechanism through Allosteric Receptor-Receptor Interactions.膜异源受体复合物作为二级蛋白质调节剂:通过变构受体-受体相互作用的新型整合机制。
Membranes (Basel). 2024 Apr 25;14(5):96. doi: 10.3390/membranes14050096.
4
Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants.天然血清素转运体与精神兴奋剂复合物的结构和膜相互作用。
Proc Natl Acad Sci U S A. 2023 Jul 18;120(29):e2304602120. doi: 10.1073/pnas.2304602120. Epub 2023 Jul 12.
5
clinical trial evaluating lisdexamfetamine's and methylphenidate's mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients' population.在注意缺陷多动障碍虚拟患者群体中评估赖右苯丙胺和哌甲酯作用机制计算模型的临床试验。
Front Psychiatry. 2023 Jun 2;14:939650. doi: 10.3389/fpsyt.2023.939650. eCollection 2023.
6
Blunted Amphetamine-induced Reinforcing Behaviors and Transporter Downregulation in Knock-in Mice Carrying Alanine Mutations at Threonine-258 and Serine-259 of Norepinephrine Transporter.携带去甲肾上腺素转运蛋白第 258 位苏氨酸和第 259 位丝氨酸丙氨酸突变的敲入小鼠中,安非他命诱导的强化行为和转运体下调变钝。
J Mol Neurosci. 2022 Sep;72(9):1965-1976. doi: 10.1007/s12031-022-01988-x. Epub 2022 Jul 19.
7
Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.神经激肽-1 拮抗剂区分了去甲肾上腺素转运体和多巴胺转运体在介导安非他命行为中的作用。
Pharmacology. 2021;106(11-12):597-605. doi: 10.1159/000518033. Epub 2021 Sep 2.
8
Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.脂质微区对单胺转运体和受体的调节:与抑郁症的关系。
Neuropsychopharmacology. 2018 Oct;43(11):2165-2179. doi: 10.1038/s41386-018-0133-6. Epub 2018 Jun 28.
9
Interference of norepinephrine transporter trafficking motif attenuates amphetamine-induced locomotor hyperactivity and conditioned place preference.去甲肾上腺素转运蛋白运输基序的干扰可减弱安非他命引起的运动过度兴奋和条件性位置偏爱。
Neuropharmacology. 2018 Jan;128:132-141. doi: 10.1016/j.neuropharm.2017.10.005. Epub 2017 Oct 4.
10
Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.临床上使用的神经激肽-1受体拮抗剂阿瑞匹坦对条件性精神兴奋剂与阿片类奖赏表达的不同作用。
Psychopharmacology (Berl). 2017 Feb;234(4):695-705. doi: 10.1007/s00213-016-4504-6. Epub 2016 Dec 24.

本文引用的文献

1
Inhibition of dopamine transporter activity by G protein βγ subunits.G 蛋白 βγ 亚基对多巴胺转运体活性的抑制作用。
PLoS One. 2013;8(3):e59788. doi: 10.1371/journal.pone.0059788. Epub 2013 Mar 26.
2
The solute carrier 6 family of transporters.溶质载体 6 家族转运蛋白。
Br J Pharmacol. 2012 Sep;167(2):256-78. doi: 10.1111/j.1476-5381.2012.01975.x.
3
Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function.人血清素转运蛋白的酪氨酸磷酸化:在转运蛋白稳定性和功能中的作用。
Mol Pharmacol. 2012 Jan;81(1):73-85. doi: 10.1124/mol.111.073171. Epub 2011 Oct 12.
4
Proteins interacting with monoamine transporters: current state and future challenges.与单胺转运体相互作用的蛋白质:现状与未来挑战。
Biochemistry. 2011 Aug 30;50(34):7295-310. doi: 10.1021/bi200405c. Epub 2011 Aug 5.
5
Protein phosphatase 2A mediates resensitization of the neurokinin 1 receptor.蛋白磷酸酶 2A 介导了神经激肽 1 受体的再敏化。
Am J Physiol Cell Physiol. 2011 Oct;301(4):C780-91. doi: 10.1152/ajpcell.00096.2011. Epub 2011 Jul 27.
6
Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.突触前 5-羟色胺转运体与 A₃ 腺苷受体的共定位和调节的物理关联。
Mol Pharmacol. 2011 Sep;80(3):458-65. doi: 10.1124/mol.111.071399. Epub 2011 Jun 24.
7
Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase.可卡因上调去甲肾上腺素转运蛋白需要 p38 丝裂原活化蛋白激酶对苏氨酸 30 的磷酸化。
J Biol Chem. 2011 Jun 10;286(23):20239-50. doi: 10.1074/jbc.M111.226811. Epub 2011 Apr 15.
8
Activation of the neurokinin-1 receptor in rat spinal astrocytes induces Ca2+ release from IP3-sensitive Ca2+ stores and extracellular Ca2+ influx through TRPC3.大鼠脊髓星形胶质细胞中神经激肽-1 受体的激活可诱导 IP3 敏感钙库中的 Ca2+释放和通过 TRPC3 的细胞外 Ca2+内流。
Neurochem Int. 2010 Dec;57(8):923-34. doi: 10.1016/j.neuint.2010.09.012. Epub 2010 Oct 7.
9
Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis.苏氨酸 258 和丝氨酸 259 基序在安非他命诱导的去甲肾上腺素转运体胞吞作用中的参与。
J Neurochem. 2010 Oct;115(1):23-35. doi: 10.1111/j.1471-4159.2010.06898.x. Epub 2010 Jul 30.
10
Dopamine transporter trafficking: rapid response on demand.多巴胺转运体的运输:按需快速响应。
Future Neurol. 2010 Jan 1;5(1):123. doi: 10.2217/fnl.09.76.

调节性去甲肾上腺素转运体与神经激肽-1 受体的相互作用确立了转运体的亚细胞定位。

Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.

机构信息

From the Department of Neurosciences, Division of Neuroscience Research, Medical University of South Carolina, Charleston, South Carolina 29425 and.

出版信息

J Biol Chem. 2013 Oct 4;288(40):28599-610. doi: 10.1074/jbc.M113.472878. Epub 2013 Aug 26.

DOI:10.1074/jbc.M113.472878
PMID:23979140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3789959/
Abstract

Neurokinin-1 receptor (NK1R) mediates down-regulation of human norepinephrine (NE) transporter (hNET) via protein kinase C (PKC). However, native NET regulation by NK1R and the mechanism by which NK1R targets NET among other potential effectors are unknown. Effect of NK1R activation on native NET regulation and NET/NK1R interaction were studied using rat brain synaptosomes expressing native NET and NK1R as well as human placental trophoblast (HTR) cells coexpressing WT-hNET or NK1R/PKC-resistant hNET-T258A,S259A double mutant (NET-DM) and hNK1R. The selective NK1R agonist, GR73632, and Substance-P (SP) inhibited NE transport and reduced plasma membrane expression of NET and NK1R. Pretreatment with the NK1R antagonist, EMEND (aprepitant) prevented these NK1R-mediated effects. Immunoprecipitation experiments showed that NET forms stable complexes with NK1R. In HTR cells, combined biotinylation and immunoprecipitation studies revealed plasma membrane localization of NET·NK1R complexes. Receptor activation resulted in the internalization of NET·NK1R complexes. Lipid raft and immunoprecipitation analyses revealed the presence of NET·NK1R complexes exclusively in non-raft membrane fractions under basal/unstimulated conditions. However, NK1R activation led to translocation of NET·NK1R complexes to raft-rich membrane fractions. Importantly, PKCα was found in association with raft-localized NET following SP treatment. Similar to WT-NET, PKC-resistant NET-DM was found in association with NK1R exclusively in non-raft fractions. However, SP treatment failed to translocate NET-DM·NK1R complexes from non-raft fractions to raft fractions. Collectively, these results suggest that NK1R forms physical complexes with NET and that the receptor-mediated Thr(258) + Ser(259) motif-dependent translocation of NET·NK1R complexes into raft-rich microdomains facilitates NET/NK1R interaction with PKCα to coordinate spatially restricted NET regulation.

摘要

神经激肽-1 受体 (NK1R) 通过蛋白激酶 C (PKC) 介导下调人去甲肾上腺素 (NE) 转运体 (hNET)。然而,NK1R 对天然 NET 的调节以及 NK1R 在其他潜在效应器中靶向 NET 的机制尚不清楚。使用表达天然 NET 和 NK1R 的大鼠脑突触体以及共表达 WT-hNET 或 NK1R/ PKC 抗性 hNET-T258A、S259A 双突变体 (NET-DM) 和 hNK1R 的人胎盘滋养层 (HTR) 细胞,研究了 NK1R 激活对天然 NET 调节和 NET/NK1R 相互作用的影响。选择性 NK1R 激动剂 GR73632 和 P 物质 (SP) 抑制 NE 转运并减少 NET 和 NK1R 的质膜表达。NK1R 拮抗剂 EMEND (阿瑞匹坦) 预处理可防止这些 NK1R 介导的作用。免疫沉淀实验表明 NET 与 NK1R 形成稳定的复合物。在 HTR 细胞中,联合生物素化和免疫沉淀研究显示 NET·NK1R 复合物位于质膜上。受体激活导致 NET·NK1R 复合物内化。脂质筏和免疫沉淀分析显示,在基础/未刺激条件下,NET·NK1R 复合物仅存在于非筏膜部分。然而,NK1R 激活导致 NET·NK1R 复合物向富含筏的膜部分转移。重要的是,在用 SP 处理后发现 PKCα 与筏定位的 NET 相关。与 WT-NET 类似,PKC 抗性 NET-DM 仅与非筏部分的 NK1R 相关。然而,SP 处理未能将 NET-DM·NK1R 复合物从非筏部分转移到筏部分。总之,这些结果表明 NK1R 与 NET 形成物理复合物,并且受体介导的 Thr(258)+Ser(259)基序依赖性 NET·NK1R 复合物易位到富含筏的微区,促进 NET/NK1R 与 PKCα 的相互作用,以协调空间受限的 NET 调节。